Drummond Group Plans to Offer ePCS Certification

Share Article

Drummond Group has submitted e-Prescribing of Controlled Substances Certification Process documentation to the DEA

News Image
Drummond Group’s ePCS Certification Program will certify ePCS functionality in healthcare software applications to ensure they comply with the requirements delineated in the DEA’s final rule.

Drummond Group Inc. (DGI), the trusted interoperability test lab, last week submitted to the DEA its e-Prescribing of Controlled Substances (ePCS) Certification Process documentation. The DEA is currently reviewing this ePCS Certification Process for approval. Upon approval, DGI will be providing ePCS certification to healthcare software companies with the capability of e-Prescribing controlled substances.

Since 2005, Drummond Group has been the lead auditor and certification organization for the DEA's final rule regulations on the Controlled Substance Ordering System (CSOS). CSOS enables drug manufacturers, distributors and pharmacies to electronically automate the order and fulfillment supply chain of controlled substances. Drummond Group also serves as an Authorized Testing and Certification Body (ATCB) under the Health and Human Services’ (HHS) electronic health records (EHR) certification program and has certified more than 450 software applications, including e-Prescribing solutions, since its inception in 2010.

"Given our background in auditing CSOS and the volume of e-Prescribing solutions we have tested and certified under the ATCB program, we are excited and fully prepared to launch our ePCS Certification Program, upon approval," says Rik Drummond, CEO of Drummond Group.

Drummond Group’s ePCS Certification Program will certify ePCS functionality in healthcare software applications to ensure they comply with the requirements delineated in the DEA’s final rule, 21 CFR Part 1311. The ePCS final rule is designed to further the adoption of e-Prescribing by specifically addressing controlled substances prescriptions between practitioners and pharmacies by taking significant measures to ensure that the process is secure and enforces diversion control measures of controlled substances.

Among the requirements, practitioners and pharmacies must select and use e-Prescribing software that has undergone review by a certification organization that has had its ePCS Certification Process approved by the DEA. Using healthcare applications that have certified ePCS capability will empower individual and institutional practitioners to write prescriptions with controlled substances electronically and pharmacies to receive, dispense and archive these electronic prescriptions.

To receive the latest updates on Drummond Group’s ePCS Certification Program, please email epcs(at)drummondgroup(dot)com and visit our website:
http://www.drummondgroup.com/html-v2/EPCS/

For more information about CSOS, please visit:
http://www.drummondgroup.com/html-v2/csos.html

About Drummond Group Inc.
Drummond Group Inc., the trusted software test lab, provides effective and efficient testing for healthcare information technology vendors. As an Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB), Drummond Group works closely with healthcare software vendors to certify EHRs for use by providers that are looking to qualify for incentive funds under the American Recovery and Reinvestment Act (ARRA). Drummond Group is approved to certify both complete and modular EHR for both ambulatory and inpatient. Drummond Group also audits and certifies CSOS software for the pharmaceutical distribution industry. Leveraging more than a decade’s worth of interoperability, conformance testing and certification experience in multiple industries, Drummond Group delivers what’s needed in healthcare: highly reliable and readily affordable software testing services. For more information, go to: http://www.drummondgroup.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Olga Finneran